Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories (CH:ABT)
:ABT
ABT Analyst Ratings
Strong Buy
18 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ABT Stock 12 Month Forecast
Average Price Target
CHF119.38
▲(12.62% Upside)
| Highest Price TargetCHF131.67 | Average Price TargetCHF119.38 | Lowest Price TargetCHF105.17 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Stifel Nicolaus
Reiterated
04/14/25
TD Cowen
Reiterated
04/10/25
Oppenheimer
Reiterated
04/08/25
Wells Fargo
Reiterated
04/07/25
Piper Sandler
Reiterated
04/04/25
Barclays
Reiterated
03/31/25
Citi
Reiterated
03/28/25
Bank of America Securities
Reiterated
03/27/25
BTIG
Reiterated
03/27/25
Goldman Sachs
Reiterated
03/04/25
Argus Research
CHF118.56→CHF122.65
Buy
15.71%
Upside
Reiterated
01/28/25
Argus Research Sticks to Their Buy Rating for Abbott Laboratories (ABT)
Mizuho Securities
―
Hold
―
Assigned
01/23/25
Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT)
UBS
CHF119.38→CHF121.01
Buy
14.16%
Upside
Reiterated
01/23/25
Abbott price target raised to $148 from $146 at UBS, shares remain undervaluedAbbott price target raised to $148 from $146 at UBS, shares remain undervalued
Morgan Stanley
CHF95.67
Hold
-9.75%
Downside
Reiterated
01/23/25
Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook
Bernstein
CHF110.38→CHF112.84
Buy
6.45%
Upside
Reiterated
01/22/25
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
04/14/25
TD Cowen
Reiterated
04/10/25
Oppenheimer
Reiterated
04/08/25
Wells Fargo
Reiterated
04/07/25
Piper Sandler
Reiterated
04/04/25
Barclays
Reiterated
03/31/25
Citi
Reiterated
03/28/25
Bank of America Securities
Reiterated
03/27/25
BTIG
Reiterated
03/27/25
Goldman Sachs
Reiterated
03/04/25
Argus Research
CHF118.56→CHF122.65
Buy
15.71%
Upside
Reiterated
01/28/25
Argus Research Sticks to Their Buy Rating for Abbott Laboratories (ABT)
Mizuho Securities
―
Hold
―
Assigned
01/23/25
Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT)
UBS
CHF119.38→CHF121.01
Buy
14.16%
Upside
Reiterated
01/23/25
Abbott price target raised to $148 from $146 at UBS, shares remain undervaluedAbbott price target raised to $148 from $146 at UBS, shares remain undervalued
Morgan Stanley
CHF95.67
Hold
-9.75%
Downside
Reiterated
01/23/25
Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook
Bernstein
CHF110.38→CHF112.84
Buy
6.45%
Upside
Reiterated
01/22/25
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating
Best Analysts Covering Abbott Laboratories
Which Analyst Should I Follow If I Want to Buy CH:ABT and Sell After:
1 Month
xxx
Success Rate
17/25 ratings generated profit
Average Return
+0.97%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.00% of your transactions generating a profit, with an average return of +0.97% per trade.
3 Months
xxx
Success Rate
20/25 ratings generated profit
Average Return
+5.43%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +5.43% per trade.
1 Year
2 Years
xxx
Success Rate
18/22 ratings generated profit
Average Return
+14.14%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +14.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ABT Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
43
34
27
33
23
Hold
3
2
2
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
36
29
35
23
Each month's total comprises the sum of three months' worth of ratings.
ABT Financial Forecast
ABT Stock Forecast FAQ
What is CH:ABT’s average 12-month price target, according to analysts?
Based on analyst ratings, Abbott Laboratories’s 12-month average price target is 119.38.
What is CH:ABT’s upside potential, based on the analysts’ average price target?
Abbott Laboratories has 12.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Abbott Laboratories a Buy, Sell or Hold?
Abbott Laboratories has a consensus rating of Strong Buy, which is based on 18 buy ratings, 3 hold ratings and 0 sell ratings.
What is Abbott Laboratories’s share price target?
The average share price target for Abbott Laboratories is 119.38. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF131.67 ,and the lowest forecast is CHF105.17. The average share price target represents 12.62% Increase from the current price of CHF106.
The highest analyst share price target is CHF131.67 ,and the lowest forecast is CHF105.17. The average share price target represents 12.62% Increase from the current price of CHF106.
What do analysts say about Abbott Laboratories?
Abbott Laboratories’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of Abbott Laboratories?
To buy shares of CH:ABT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.